TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
INMD

InMode Ltd

Healthcare · Medical Devices

13.20$ -3.9% vs. previous close Closing price · As of: Nov 12, 2026

Ownership

Ownership Structure

Who owns InMode Ltd (INMD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.4% of the shares are freely tradable; institutional investors hold 59.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 59.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 13.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 85.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 58Mio.

Largest Shareholders

Institutions

Institutions INMD
Name Stake (%) Shares Change (%) Date
Doma Perpetual Capital Management LLC 4.75 2,730,931 -11.0 06/30/2026
Acadian Asset Management LLC 4.49 2,583,988 -0.4 06/30/2026
BlackRock Inc 4.34 2,495,402 +10.7 06/30/2026
Renaissance Technologies Corp 4.16 2,391,318 -7.5 06/30/2026
MENORA MIVTACHIM HOLDINGS LIMITED 3.55 2,040,000 +0.0 06/30/2026
Steel Partners Holdings LP 3.18 1,828,815 +1.9 06/30/2026
Millennium Management LLC 3.04 1,751,972 +50.8 06/30/2026
Morgan Stanley - Brokerage Accounts 1.94 1,115,207 -15.8 06/30/2026
Systematic Financial Management LP 1.77 1,015,754 -12.0 06/30/2026
Jupiter Topco LLC 1.68 966,020 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?